A new study shows that kidney cancer rates in Merrimack are about 38% higher than expected and points to another possible ...

AstraZeneca (NASDAQ:AZN) and partner Daiichi Sankyo (OTCPK:DSKYF) (OTCPK:DSNKY) on Saturday announced data from two ...

A groundbreaking study reveals that cancer patients who received a COVID-19 mRNA vaccine within 100 days of starting ...

A study found industrialized communities east of Houston may be at elevated risk of developing several types of cancer. But ...

Findings complement previously announced results in triple-negative breast cancer (TNBC) and prostate cancer models, highlighting Telomir-1’s consistent impact on cancer cell survival pathways. MIAMI, ...

Top U.S. cancer centers have launched a federated AI platform, letting models learn from patient data securely to accelerate research and treatment discoveries.

Briers led off a group of speakers in an ESMO Quality of Life session on confronting sexual dysfunction after cancer care, which included a look at data from Europa UOMO on how treatment affects ...

Three large drug companies shared new study results this week that point to more progress in breast cancer treatment. The ...

Grail announced fresh data on Friday from a large U.S. study of its flagship Galleri blood-based test for detecting dozens of ...

GSK may be happy with the latest readouts from two Hansoh-partnered antibody-drug conjugates (ADCs), but the Big Pharma’s ...

Moderna Inc. (NASDAQ: MRNA) is one of the best high volume stocks to buy according to Wall Street analysts. On October 13, ...

AstraZeneca and Daiichi Sankyo's drug Enhertu has shown strong results in two pivotal studies in the early stage of a certain ...